US Stock MarketDetailed Quotes

HOOK HOOKIPA Pharma

Watchlist
  • 1.080
  • -0.100-8.47%
Close Mar 31 16:00 ET
10.69MMarket Cap-0.31P/E (TTM)

About HOOKIPA Pharma Company

HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.

Company Profile

SymbolHOOK
Company NameHOOKIPA Pharma
Listing DateApr 18, 2019
Issue Price14.00
Founded2011
CEODr. Malte Peters, M.D.
MarketNASDAQ
Employees87
Fiscal Year Ends12-31
Address350 Fifth Avenue,72nd floor, Suite 7240
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10118
Phone43-1-890-6360
Websitehttp://www.hookipapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Malte Peters, M.D.
  • Director, Chief Executive Officer and President
  • 232.31K
  • Roman Necina
  • Chief Operations Officer
  • --
  • Mark Winderlich
  • Chief Development Officer
  • --
  • Klaus Orlinger
  • Chief Scientific Officer
  • --
  • Terry Coelho
  • Director, Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 85.88K
  • Julie O'Neill
  • Non-Executive Chairman of the Board
  • 67.74K
  • Sean A. Cassidy
  • Independent Director
  • --
  • Dr. David Ross Kaufman, M.D.,PhD
  • Independent Director
  • 71.74K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Ecopetrol
EC
10.440
Apple
AAPL
222.130
D.R. Horton
DHI
127.130
4
Meritage Homes
MTH
70.880
5
Lennar Corp
LEN
114.780
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.